Liver Fibrosis Clinical Trials in Hangzhou
3 recruitingHangzhou, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic dysfunction-associated steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim1,800 enrolled526 locationsNCT06632444
Recruiting
Not Applicable
Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis
Liver CirrhosisLiver Fibrosis
Second Affiliated Hospital, School of Medicine, Zhejiang University10 enrolled1 locationNCT07271576
Recruiting
Phase 3
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd.248 enrolled23 locationsNCT05905172